Experience of using of low-temperature argon plasma in the treatment of postacne

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: In recent years, there has been a growing number of scientific literature concerning the correction of the consequences of acne vulgaris, united by the term "post-acne symptom complex". Post-inflammatory pigmentation and postacne scars can be persistent, progress and persist for months to years, significantly reducing patients' quality of life. Moreover, consequences of acne vulgaris require expensive treatment. Thus, the problem of postacne prevention and treatment remains actual for both dermatovenerologists, cosmetologists and patients.

AIM: Clinical and morphofunctional assessment of the effectiveness and tolerability of the monotherapy of using of low-temperature argon plasma in patients with postacne.

MATERIALS AND METHODS: The study involved 15 patients with postacne (13 women and 2 men) aged 18 to 30 years, 10 of them had mild severity, 5 had moderate-to-severe postacne. All patients received monotherapy using the Plazmoran plasma arc installation. The course of treatment consisted of 10 procedures performed every other day, the observation period was 1 month. Dermatological examination was carried out visually with assessment of the severity of pigmented spots, erythema and scarring using the postacne scar scales by G.J. Goodman et al. In order to assess the morphofunctional parameters of facial skin, all patients underwent a non-invasive digital study using the Capricorn AI Intelligent Imager Bitmoji device, based on 3D visualization. To study the impact of the disease on various aspects of the patient's life and as an effectiveness criterion, the Dermatology Life Quality Index (DLQI) was used.

RESULTS: In the majority of patients using Plazmoran monotherapy a reduction in postacne manifestations was observed within the first 2 weeks. Moreover, there was a significant regression of inflammatory elements, the skin texture was improved. As a result of the treatment, significant improvement was achieved in 10 patients and improvement in 5. At the end of the entire observation period, according to the questionnaire, the subjects observed a decrease in DLQI compared with the baseline (15.6±3.4 vs. 8.3±0.9; p <0.05), which indicates an improvement of the quality of life and psychoemotional state of patients and the effectiveness of therapy.

CONCLUSION: The Plazmoran plasma arc installation is a highly effective method for correcting and preventing the development of the post-acne symptom complex of mild and moderate severity, which is as confirmed based on the results of a visual examination and the positive dynamics of indicators of superficial and deep analysis of facial skin (sebumetry, corneometry, pigmentation, reactivity and level colonization by Cutibacterium acnes). The procedure is well tolerated by patients with no any adverse events.

全文:

受限制的访问

作者简介

Olga Olisova

The First Sechenov Moscow State Medical University (Sechenov University)

Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN 代码: 2500-7989

MD, Dr. Sci. (Medicine), Professor, Corresponding Member of the Russian Academy of Sciences

俄罗斯联邦, Moscow

Lyailya Kayumova

The First Sechenov Moscow State Medical University (Sechenov University)

编辑信件的主要联系方式.
Email: avestohka2005@inbox.ru
ORCID iD: 0000-0003-0301-737X
SPIN 代码: 4391-9553

MD, Cand. Sci. (Medicine), Assistant Professor

俄罗斯联邦, Moscow

Anastasia Shepeleva

The First Sechenov Moscow State Medical University (Sechenov University)

Email: dr.shepelevaavl@gmail.com
ORCID iD: 0009-0001-5251-5394
俄罗斯联邦, Moscow

Anna Gurtovnik

The First Sechenov Moscow State Medical University (Sechenov University)

Email: gurtovnik.anna@gmail.com
ORCID iD: 0009-0002-2256-4993
SPIN 代码: 7963-6040
俄罗斯联邦, Moscow

Anastasia Kostina

The First Sechenov Moscow State Medical University (Sechenov University)

Email: nastyakostinaa@mail.ru
ORCID iD: 0009-0003-0313-1137
俄罗斯联邦, Moscow

参考

  1. Fabbrocini G, Annunziata MC, D’Arco V, et al. Acne scars: Pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080
  2. Goodman GJ, Baron JA. Postacne scarring: A quantitative global scarring grading system. J Cosmet Dermatol. 2006;5(1):48–52. doi: 10.1111/j.1473-2165.2006.00222.x
  3. Ostretsova MN, Snarskaya ES, Tkachenko SB, Allenova AS. Modern approach to diagnostics, prevention and correction of acne scarring on the basis of study of skin morphology by noninvasive methods. Vestnik dermatologii i venerologii. 2018;94(2):41–47. EDN: UTIRPS doi: 10.25208/0042-4609-2018-94-2-41-47
  4. Olisova OYu, Avagyan DV. Treatment of postoperative scars with combined use of СО2 laser ablation and autologous platelet enriched plasma. Russ J Skin Venereal Dis = Rossiyskii zhurnal kozhnykh i venericheskikh boleznei. 2018;21(1):48–52. EDN: XTCGQX doi: 10.18821/1560-9588-2018-21-1-48-52
  5. Liang Y, Li L. The combination of red and blue light, radiofrequency and intense pulsed light for the treatment of facial postacne erythema. Clin Cosmet Investig Dermatol. 2022;15:2383–2389. doi: 10.2147/CCID.S389705
  6. Kruglova LS, Griazeva NV, Talibova AM. Post-acne symptom complex: Methods of prevention and therapy. Russi J Clin Dermatol Venereol = Klinicheskaya dermatologiya i venerologiya. 2020;19(5):622–629. EDN: JKCBFA doi: 10.17116/klinderma202019051622
  7. Frolov SA, Kuzminov AM, Vyshegorodtsev DV, et al. Possibilities for the application of low-temperature argon plasma in the treatment of postoperative and long-term non-healing wounds. Russ J Gastroenterology, Hepatology, Coloproctology = Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2019;29(6):15–21. EDN: QLJGGX doi: 10.22416/1382-4376-2019-29-6-15-21
  8. Busco G, Robert E, Chettouh-Hammas N, et al. The emerging potential of cold atmospheric plasma in skin biology. Free Radic Biol Med. 2020;161:290–304. doi: 10.1016/j.freeradbiomed.2020.10.004
  9. Moisan M, Barbeau J, Moreau S, et al. Low-temperature sterilization using gas plasmas: A review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm. 2001;226(1-2):1–21. doi: 10.1016/s0378-5173(01)00752-9
  10. Zhai SY, Kong MG, Xia YM. Cold atmospheric plasma ameliorates skin diseases involving reactive oxygen/nitrogen species-mediated functions. Front Immunol. 2022;13:868386. doi: 10.3389/fimmu.2022.868386
  11. Li M, Gao J, Wang L, et al. Basic research and clinical exploration of cold atmospheric plasma for skin wounds. Bioeng Transl Med. 2023;8(5):e10550. doi: 10.1002/btm2.10550
  12. Oliver MA, Hussein LK, Molina EA, et al. Cold atmospheric plasma is bactericidal to wound-relevant pathogens and is compatible with burn wound healing. Burns. 2024;50(5):1192–1212. doi: 10.1016/j.burns.2023.12.012
  13. Barjasteh A, Kaushik N, Choi EH, Kaushik NK. Cold atmospheric pressure plasma: A growing paradigm in diabetic wound healing-mechanism and clinical significance. Int J Mol Sci. 2023;24(23):16657. doi: 10.3390/ijms242316657
  14. Tan F, Wang Y, Zhang S, et al. Plasma dermatology: Skin therapy using cold atmospheric plasma. Front Oncol. 2022;12:918484. doi: 10.3389/fonc.2022.918484
  15. Cho SB, Kim HJ, Kim H, Yoo KH. Argon plasma: A new approach for the effective treatment of inflammatory acne vulgaris and enlarged pores in Asian patients. Medical Lasers. 2018;7(2):97–101. doi: 10.25289/ML.2018.7.2.97
  16. Mariachiara DA, Venturuzzo A, Gelmetti A, et al. Cold atmospheric plasma (CAP) as a promising therapeutic option for mild to moderate acne vulgaris: Clinical and non-invasive evaluation of two cases. Clin Plasma Med. 2020;19-20:100110. doi: 10.1016/j.cpme.2020.100110
  17. Korotkiy VN, Udzhukhu VYu, Kubylinskiy AA, Karamova AA. Cold atmospheric plasma in complex acne therapy. Russ J Clin Dermatol Venereol = Klinicheskaya dermatologiya i venerologiya. 2020;19(6):914–918. doi: 10.17116/klinderma202019061914
  18. Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the United States. J Drugs Dermatol. 2017;16(2):97–102.

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. Plasma-arc surgical unit Plasmoran: a ― appearance of the device; b ― gas-dynamic flow in the form of intense optical radiation.

下载 (730KB)
3. Fig. 2. Capricorn AI Intelligent Imager Bitmoji device: a ― appearance of the device; b ― measurement of morphofunctional indices of facial skin.

下载 (1MB)
4. Fig. 3. Superficial and deep skin analysis using 8-spectral imaging.

下载 (656KB)
5. Fig. 4. Mild severity of post-acne in patients before and after treatment: а, b ― significant improvement achieved; c, d ― improvement achieved.

下载 (3MB)
6. Fig. 5. Moderate to severe post-acne lesions in patients before and after treatment: а, b ― significant improvement achieved; c ― improvement achieved.

下载 (2MB)
7. Fig. 6. 3D modelling using negative polarising light before the study (a) and at the end of the course (b): no skin reactivity.

下载 (1MB)
8. Fig. 7. The severity of pigment spots before the study and after 2 weeks of treatment: а, b ― superficial analysis mode; c, d ― deep analysis mode.

下载 (2MB)
9. Fig. 8. Prominent seboregulatory effect in patients before (a) and after (b) low-temperature atmospheric plasma treatments: areas of sebum are highlighted in yellow.

下载 (1MB)
10. Fig. 9. Colonisation of Cutibacterium acnes in sebaceous glands of patients before the study (a) and after treatment (b) (decrease in porphyrin fluorescence luminescence intensity is noted).

下载 (1MB)
11. Fig. 10. Skin analysis by corneometry in patients before the study (a) and after treatment (b).

下载 (1MB)

版权所有 © Eco-Vector, 2024



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.